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Background: Being overweight or obese increases risk for cardiometabolic disorders. Although both body mass
index (BMI) and waist circumference (WC) measure the level of overweight and obesity, WC may be more
important because of its closer relationship to total body fat. Because WC is typically not assessed in clinical
practice, this study sought to develop and verify a model to predict WC from BMI and demographic data, and to
use the predicted WC to assess cardiometabolic risk.
Methods: Data were obtained from the Third National Health and Nutrition Examination Survey (NHANES) and the
Atherosclerosis Risk in Communities Study (ARIC). We developed linear regression models for men and women
using NHANES data, fitting waist circumference as a function of BMI. For validation, those regressions were applied
to ARIC data, assigning a predicted WC to each individual. We used the predicted WC to assess abdominal obesity
and cardiometabolic risk.
Results: The model correctly classified 88.4% of NHANES subjects with respect to abdominal obesity. Median
differences between actual and predicted WC were − 0.07 cm for men and 0.11 cm for women. In ARIC, the model
closely estimated the observed WC (median difference: − 0.34 cm for men, +3.94 cm for women), correctly
classifying 86.1% of ARIC subjects with respect to abdominal obesity and 91.5% to 99.5% as to cardiometabolic risk.
The model is generalizable to Caucasian and African-American adult populations because it was constructed from
data on a large, population-based sample of men and women in the United States, and then validated in a
population with a larger representation of African-Americans.
Conclusions: The model accurately estimates WC and identifies cardiometabolic risk. It should be useful for health
care practitioners and public health officials who wish to identify individuals and populations at risk for
cardiometabolic disease when WC data are unavailable.Background
Body mass index (BMI), defined as weight in kilograms
divided by the square of height in meters, has long been
an important measure of excess body fat, and a high BMI
is a well-recognized risk factor for cardiometabolic disor-
ders. BMI is easily obtained and commonly assessed in
clinical settings, and most current standards for over-
weight (BMI≥ 25 kg/m2) and obesity (BMI≥ 30 kg/m2) are
based on BMI [1]. Current World Health Organization
guidelines for cardiometabolic risk employ these thresh-
olds [2]. Recent research, however, suggests that the* Correspondence: chris.pashos@unitedbiosource.com
†Equal contributors
4United BioSource Corporation, Lexington, MA, USA
Full list of author information is available at the end of the article
© 2012 Bozeman et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordistribution of body fat, for which BMI does not account,
is a more important indicator of cardiovascular risk [3]. In
particular, increased visceral fat has been shown to be an
important risk factor for cardiovascular disease and dia-
betes, among other metabolic disorders [4–6]. An indica-
tor of visceral fat, waist circumference (WC), is more
sensitive to the distribution of body fat than is BMI [7],
and therefore a better surrogate measure of android adi-
posity [8]. Previous work has attempted to define the link
between the two measures by identifying BMI ranges that
are equivalent in risk of cardiovascular events to WC
ranges in current guidelines [9]. Current definitions of car-
diometabolic risk factors, including guidelines issued by
the National Cholesterol Education Program Adult Treat-
ment Panel III (NCEP-ATP III) and International Diabetesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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clude WC [10]. Previous research has demonstrated the
prevalence of these conditions in well-characterized U.S.
populations [11,12]. However, given the historical use of
BMI in clinical practice, WC is not as widely available in
established clinical databases. We sought to determine how
closely WC could be predicted from BMI and two or three
important demographic covariates — gender, age, and (op-
tionally) race and ethnicity — as a basis for imputing WC
when only BMI or weight and height are available, and to
use the predicted WC to assess cardiometabolic risk.
Methods
Data
Following institutional review board approval by the Abt
Associates Institutional Review Board, de-identified data
were obtained for this study from two large studies: (1)
the Third National Health and Nutrition Examination
Survey (NHANES) 2001–2002 cohort and (2) the Athero-
sclerosis Risk in Communities Study (ARIC). The analyt-
ical model was built using data from NHANES, a national
probability sample of the United States population collect-
ing information on health and nutritional status [13]. Files
contain both WC and BMI measurements, as well as
demographic characteristics data, including age, gender,
race, and ethnicity. The NHANES 2001–2002 data set
contains data for 11,039 persons. We included individuals
18 years of age or older with no missing data on WC and
BMI and excluded individuals with BMI> 40 kg/m2, which
yielded a study sample of 4,641 adults.
To validate the gender-specific models, we applied them
to data from ARIC, a prospective study of community
sites in Maryland, Mississippi, Missouri, and North Caro-
lina that examined risk factors and the natural history of
atherosclerosis and cardiovascular disease in an ethnically
diverse population [14]. A cohort of nearly 16,000 was
examined at baseline (1987) and re-examined four times
at 3-year intervals. Examinations included extensive la-
boratory tests and anthropometric assessments. In
addition to periodic medical examinations, study staff
conducted yearly follow-up telephone interviews to up-
date the health status of each participant. Analyses pre-
sented here use data collected between 1996 and 1998 at
Examination 4, which included 11,596 study participants.
Model for WC
An initial model expressed the regression of WC on
BMI in the following form:
WCi ¼ b0 þ b1BMIi þ b2AGEi þ b3BLACKi
þ b4HISPi þ ei
ð1Þ
where i indexes individuals, WCi is waist circumference
for individual i, BMIi is body mass index, AGEi is currentage (in years), BLACKi is an indicator for African-Ameri-
can, HISPi is an indicator for Hispanic ethnicity, and ei is
the residual. Because the relation of WC to BMI involved
nonlinearity when BMI> 40 kg/m2 for both sexes, we
based the models on data from individuals with
BMI≤ 40 kg/m2. (For individuals with BMI> 40 kg/m2 it is
unlikely that a value of WC, either measured or predicted,
will be needed as a guide to treatment.) An exploratory
analysis, fitting a separate constant for each 2-year interval
of age, revealed that the contribution of age to the model
differed between men and women. For men the contribu-
tion was well summarized by a linear term in age, as in
Equation 1. For women the pattern was better summar-
ized by using one constant for age < 35 years and a separ-
ate intercept and slope for age≥ 35 years. Thus, the model
for women was
WCi ¼ c0 þ c1BMIi þ c2 I AGEi≥35f g þ c3AGEi
 I AGEi≥35f g þ c4BLACKi þ c5HISPi þ ei
ð2Þ
where I Bf g is an indicator function: I Bf g ¼ 1 when B is
true and 0 otherwise. The contributions of race and ethni-
city were adequately accounted for by those indicator vari-
ables; separate models were not necessary. Because
NHANES used a complex sample design and oversampled
certain segments of the population, the regressions took
into account the sample design and survey weights.
We developed two additional models (one for men
and one for women) omitting the BLACKi and HISPi
variables. The results were essentially the same, and are
available upon request.
Validation
The linear regression models derived from the NHANES
data yielded a predicted waist circumference for every
individual in the ARIC dataset with BMI ≤ 40 kg/m2 and
AGE < 70 years. We applied the restriction on AGE be-
cause the variable had been recoded to 70 for individuals
who should have had AGE= 71, 72, or 73 years; the cor-
rect values were not available. In addition, we recalcu-
lated each individual’s BMI from the reported values of
weight and height after we discovered that, for a small
percentage of individuals, the reported BMI differed
from the calculated BMI by a substantial amount. We
computed the difference between observed and pre-
dicted waist circumference for each individual, and used
the mean and various percentiles to summarize those
differences. Examination of the distributions of differ-
ences from the two models revealed a moderate number
of large values, which we investigated further.
Definitions of the seven cardiometabolic risk factor
sets are presented in Table 1 [10]. We assessed member-
ship in each defined risk factor set using the actual and
Table 2 Characteristics of NHANES 2001–2 sample
Men (N=2,246) Women (N=2,395)
Mean Std. Error Mean Std. Error
Age 43.95 0.559 44.64 0.531
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We computed sensitivity, specificity, and positive pre-
dictive value (PPV) using the predicted waist circumfer-
ence as a “screening test” against the measured waist





WC 97.4 0.295 90.5 0.384





Characteristics of persons in the NHANES 2001–2002
sample used to develop the model are representative
of the U.S. population, with an average age near
44 years, predominantly white, and with an average
BMI in the overweight but not obese range (Table 2).
Coefficients for the models are presented in Table 3.
To estimate WC, the coefficients and the values of
the predictors are substituted into the equations. For
example, the predicted WC of a 40-year-old white
non-Hispanic man with a BMI of 35 kg/m2 is com-
puted as: 22.61306 + 2.520738*(35) + 0.1583812*(40)
− 3.703501*(0)− 1.736731*(0) = 117.2 cm. The pre-
dicted WC for a 50-year-old black non-Hispanic
woman with a BMI of 28 kg/m2 is computed as
28.81919 + 2.218007*(28)− 3.688953*(1)+ 0.125975*(50)





AO +Diabetes AO +Dy
≥3 of the following
risk factors
High WC High WC + diabetes High WC
TG or low
WC Men≥ 102 cm Men≥ 102 cm Men≥ 102 cm Men≥ 10
Women≥ 88 cm Women≥ 88 cm Women≥ 88 cm Women≥
TG ≥ 150 mg/dL NA NA ≥ 150 m
HDL Men< 40 mg/dL NA NA Men< 40
Women< 50 mg/dL Women<
BP SBP≥ 130 mm Hg or NA NA NA









WC waist circumference, TG triglycerides, HDL high-density lipoprotein, BP blood pr
Program, ATP III Adult Treatment Panel III.
a Ford, E. S. Prevalence of the metabolic syndrome defined by the International Dia
b For White and African American subjects. Refer to a Ford, E.S. article for other ethnFor men, the predicted WC is reasonably close to the
actual WC, and for women it is somewhat less close
than for men. The median difference (actual WC minus
predicted WC) for men is − 0.07 cm, and the middle half
of the differences extends from − 3.14 cm to + 3.00 cm.










TG or low HDL
High WC + 2 of the
other 4 risk factors
High WC
2 cm Men≥ 102 cm Men≥ 94 cmb Men≥ 94 cmb
88 cm Women≥ 88 cm Women≥ 80 cmb Women≥ 80 cmb
g/dL ≥ 150 mg/dL ≥ 150 mg/dL, or NA
on treatment for
high TG
mg/dL Men< 40 mg/dL Men< 40 mg/dL NA






NA SBP≥ 130 mm Hg or NA




(Same as for NCEP)






essure, FPG fasting plasma glucose, NCEP National Cholesterol Education
betes Federation among adults in the U.S. Diabetes Care 2005, 28:2745–2749.
ic group-specific thresholds including for Mexican-American subjects.
Table 3 Models for predicting waist circumference from BMI
Men (N=2,395) Women (N=2,246)
Coefficient Std. Error P-Value Coefficient Std. Error P-Value
Constant 22.61306 0.8792 < 0.0001 28.81919 0.8011 < 0.0001
Age 0.1583812 0.0049 < 0.0001 - - -
I {Age≥ 35} - - - −3.688953 0.8308 < 0.0001
Age× I {Age≥ 35} - - - 0.125975 0.0118 < 0.0001
BMI 2.520738 0.0338 < 0.0001 2.218007 0.0318 < 0.0001
Black −3.703501 0.3194 < 0.0001 −0.6570163 0.6730 0.344
Hispanic −1.736731 0.4848 0.003 0.1818819 0.6729 0.79
Table 4 Characteristics of ARIC sample at Examination 4
Men (N=3,806) Women (N=4,967)
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comparability with ARIC, Figure 1 shows boxplots of the
difference for men and women NHANES participants in
the age range of 54 to 69 years. In this display the box
covers the middle half of the data, from the 25th percent-
ile to the 75th percentile, and the line across it shows the
location of the median. Beyond lower and upper cutoffs
(1.5 times the interquartile range below the 25th percent-
ile and above the 75th percentile, respectively), data
values are shown individually, and the “whiskers” indi-
cate the range of the remaining data. For the 462 men in
this age range, the median difference is − 0.15 cm, and
the quartiles are at − 3.22 cm and + 3.21 cm. Three men
had differences that were sizable enough to be shown at
the ends of the boxplot (one negative and two positive).
For the corresponding 458 women, the median differ-
ence is + 0.47 cm, and the quartiles are at − 3.66 cm and
+ 4.86 cm. Eight women’s differences are beyond the cut-
offs (two high and six low). At the median the model for
women underpredicts WC slightly, and the differences
for women are considerably more variable than those for
men.
Table 4 shows the characteristics of persons in the
ARIC population used in validating the model. TheFigure 1 Boxplot of difference (cm) between actual and
predicted WC (actual WC minus predicted WC) in NHANES
participants age 54 to 69 years.average age of 61 is 17 years older than the NHANES
population. (Participants in ARIC ranged in age from 45
to 64 years at Examination 1, so the range at Examin-
ation 4 would have been, with few exceptions, 54 to
73 years.) The ARIC participants contained more
women than men (56.6% vs 43.4%), and more (especially
women) were African-American. The population is pre-
dominantly white. The mean BMI and WC values are
slightly higher for ARIC in men and women, with an
average BMI in the overweight but not obese range.
As seen in Figure 2, for the ARIC study participants as
a whole, the predicted WC is also reasonably close to
the actual WC. For men the median difference is
− 0.34 cm, and the quartiles are − 3.49 cm and
+ 2.74 cm. For women the median difference, + 3.94 cm,
corresponds to underestimation of WC; the quartiles,
− 0.79 cm and + 8.47 cm, yield an interquartile range of
9.26 cm, roughly 1.5 times the interquartile range for
men. Of the 3,806 men, 33 had differences that were
outside the cutoffs of the boxplot (12 negative and 21
positive). Only the most extreme of these, however,Mean Std. Dev Mean Std. Dev






WC (cm) 103 10.7 99 13.9
Derived BMI (kg/m2) 28.4 4.0 28.2 5.0
Height (cm) 176 6.5 162 5.9





Figure 2 Boxplot of difference (cm) between actual and
predicted WC (actual WC minus predicted WC) in ARIC
participants.
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differences, 63.6 and 57.4, were caused by errors in the
ARIC data, as we discovered from relating their height,
weight, and BMI on Examination 4 to their height and
weight on the previous examinations. Of the 4,967
women, 37 had differences beyond the cutoffs (23 nega-
tive and 14 positive). The largest positive and negative
differences reflected problems in the data. Aside from
participants with apparently misrecorded data, those
with extreme differences seemed to have combinations
of height, weight, and WC that simply were not well fit-
ted by the models. We also noticed that, of the 37
women with extreme residuals, 20 were black non-His-
panic. The similarity between Figure 2 and Figure 1 indi-
cates that, in the absence of problems in the data, the
models performed nearly as well in predicting WC for
individuals in ARIC as they did for individuals in
NHANES.
The difference between actual and predicted WC,
however, is not uniform over the range of WC. In bothTable 5 Risk Factor Set Membership from Predicted WC in AR
Risk Factor Set Observed proportion
(N) in risk set
Positive
Value
NCEP-ATP III Metabolic Syndrome 50.2% (2495) 9
IDF Metabolic Syndrome 55.2% (2744) 9
Abdominal Obesity1 (AO1) 76.4% (3795) 9
AO1 and DM 13.6% (675) 9
AO1 and Dyslipidemia 45.2% (2243) 9
AO1, DM and Dyslipidemia 9.6% (479) 9
Abdominal Obesity 2 91.8% (4560) 9
NCEP-ATP III National Cholesterol Education Program, Adult Treatment Panel III.
IDF International Diabetes Foundation.
Abdominal Obesity 1: ≥ 88 cm.
Abdominal Obesity 2: ≥ 80 cm.
DM Diabetes Mellitus.NHANES and ARIC and for both men and women, the
models tend to overpredict when WC is small and
underpredict when WC is large. Among men in both
databases overprediction is noticeable (median 2 to 3 cm
in WC intervals of width 5 cm) for WC< 95 cm. A simi-
lar degree of underprediction occurs for men in
NHANES with WC ≥ 115 cm and for men in ARIC with
WC ≥ 125 cm. Among women in both databases the pat-
tern was substantially stronger: overprediction of 3 to
5 cm (median) for WC< 85 cm, underprediction of
around 5 to 7 cm (median) for WC ≥ 115 cm in
NHANES, and underprediction increasing steadily in
ARIC from 3 cm (median) for 90 cm ≤WC ≤ 94 cm to
9 cm (median) for 120 cm ≤WC ≤ 124 cm. These pat-
terns affect membership in the risk factor sets, discussed
below.
Tables 5 and 6 present the results of using the pre-
dicted WC value to define membership in the seven car-
diometabolic risk factor sets for women and men,
respectively. For every risk factor set, the WC prediction
model is slightly more successful (i.e., a higher positive
predictive value and a higher proportion correctly identi-
fied as belonging to a particular risk factor set) for
women than for men. For women, the proportion cor-
rectly identified using the predicted WC was 93.2% or
higher for all sets except for the higher abdominal obes-
ity threshold (≥ 88 cm) alone, where the proportion cor-
rectly identified was 86.8%. The misclassified individuals
(13%) were twice as likely to be false negatives (i.e., in-
correctly classified as not obese) as opposed to false
positives. For this risk factor set, both specificity (cor-
rectly identifying non-membership for those who are
non-members — 82.6%) and sensitivity (correctly identi-
fying membership for those who are members — 88.0%)
were low. For the risk factor sets excluding metabolic
syndrome, the proportion correctly identified increases
as the number of defining criteria increases, with 99.5%IC Women; BMI≤ 40; Age< 70. (N= 4967)
Predictive Sensitivity Specificity Proportion correctly
predicted
8.1% 95.4% 98.2% 96.8%
8.7% 98.7% 98.3% 98.5%
4.2% 88.0% 82.6% 86.8%
8.8% 95.3% 99.8% 99.2%
6.9% 90.7% 97.6% 94.5%
8.9% 96.0% 99.9% 99.5%
5.7% 97.0% 51.4% 93.2%
Table 6 Risk Factor Set Membership from Predicted WC in ARIC Men; BMI≤ 40; Age< 70. (N= 3806)
Risk Factor Set Observed proportion
(N) in risk set
Positive Predictive
Value
Sensitivity Specificity Proportion correctly
predicted
NCEP-ATP III Metabolic Syndrome 49.8% (1895) 94.5% 96.9% 94.5% 95.7%
IDF Metabolic Syndrome 58.9% (2242) 93.8% 94.1% 91.1% 92.9%
Abdominal Obesity 1 (AO1) 48.8% (1857) 83.9% 87.4% 84.0% 85.7%
AO1 and DM 11.9% (454) 90.3% 89.9% 98.7% 97.6%
AO1 and Dyslipidemia 33.3% (1266) 86.0% 89.0% 92.8% 91.5%
AO1, DM and Dyslipidemia 9.2% (352) 90.3% 89.8% 99.0% 98.2%
Abdominal Obesity 2 81.2% (3089) 92.8% 93.0% 68.9% 88.5%
NCEP-ATP III National Cholesterol Education Program, Adult Treatment Panel III.
IDF International Diabetes Foundation.
Abdominal Obesity 1: ≥ 102 cm.
Abdominal Obesity 2: ≥ 94 cm.
DM Diabetes Mellitus.
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betes plus dyslipidemia set.
The positive predictive value (PPV) results using the
predicted WC were 94.2% or higher for each of the risk
factor sets. The lowest PPV was for abdominal obesity
as defined by the 88 cm threshold alone (94.2%), and the
highest PPVs were observed for the metabolic syndrome
definitions, abdominal obesity (AO) plus diabetes, and
AO plus dyslipidemia plus diabetes (all above 98%). Sen-
sitivity using predicted WC was higher than specificity
for the abdominal obesity boundaries alone and for the
IDF-defined metabolic syndrome. Specificity was higher
for NCEP-defined metabolic syndrome, AO plus dia-
betes, AO plus dyslipidemia, and AO plus diabetes plus
dyslipidemia. Except for the abdominal obesity alone
definitions, both sensitivity and specificity were 90.7% or
higher for every risk factor set. Specificity was low
(51.4%) for the 80 cm abdominal obesity threshold, indi-
cating a high number of false-positive predictions, and
thus reflecting the systematic overprediction of WC
among thinner women discussed above.
For men (Table 6), the proportion correctly identified
as belonging to a risk factor set using the predicted WC
was 91.5% or higher for all sets except abdominal obesity
alone. For the higher criterion of greater than or equal
to 102 cm, the proportion correctly identified was 85.7%;
for the lower criterion of greater than or equal to 94 cm,
the proportion correctly identified was 88.5%. Particu-
larly for the lower (94 cm) threshold, the misclassified
individuals were more likely to be false positives (i.e., in-
correctly classified as obese) than false negatives, as indi-
cated by specificities lower than sensitivities, and
reflecting the systematic overprediction of WC among
thinner men discussed above. For the risk factor sets ex-
cluding metabolic syndrome, the proportion correctly
identified increased as the number of defining criteria
increased, with 98.2% correctly identified for the abdom-
inal obesity plus diabetes plus dyslipidemia set.The positive predictive value (PPV) results using the
predicted WC for men were lowest for those risk factor
sets using the higher 102 cm threshold, ranging from
83.9% for AO alone to 90.3% for AO plus diabetes plus
dyslipidemia. The highest PPVs, 93.8% and 94.5%, were
observed for the IDF and NCEP metabolic syndrome
definitions, respectively. Sensitivity using predicted WC
was higher than specificity for the metabolic syndrome
risk factor sets and for the AO alone sets.
We also compared the results of the waist circumfer-
ence prediction model to an approach using BMI thresh-
old values to predict risk factor set membership, using
the WHO-recommended BMI values to define member-
ship in the six cardiometabolic risk factor sets. Specific-
ally, we substituted the WHO-recommended BMI values
for the waist circumference criteria as follows:
BMI ≥ 25 kg/m2 (“overweight”) corresponds to WC of
80 cm for women and 94 cm for men, and BMI≥ 30 kg/
m2 (“obese”) corresponds to WC of 88 cm for women
and 102 cm for men. Among ARIC women, the WC
prediction model categorized risk factor set membership
more accurately than the BMI threshold for every set. In
contrast, among ARIC men the results of the two
approaches differed much less. The differences in the
proportions correctly identified were within one percent-
age point for three of the seven sets, and the WC predic-
tion model categorized risk factor set membership more
accurately than the BMI threshold in the other four sets.
Tables presenting these results are available upon
request.
We repeated all of the analyses described above for a
simpler model omitting the race and ethnicity demo-
graphic variables. The results were essentially the same.
Analogous Figures 1 and 2 (the boxplots showing the
predicted WC values) and Tables 5 and 6 (the validation
exercise assessing the sensitivity, specificity, positive pre-
dictive value, and proportion correctly predicted) are
available upon request.
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We constructed a model estimating WC from BMI and
three demographic variables — gender, age, and race/
ethnicity — because WC is increasingly recognized as a
more accurate and therefore more useful metric than
BMI alone for predicting cardiometabolic risk. Using the
estimated WC value from the model more accurately
predicted cardiometabolic risk than using BMI alone.
Because the predictor variables are generally collected in
clinical practice and therefore available for assessment
by practitioners as well as health plans and public health
officials, this model may assist in the accurate identifica-
tion of individuals at higher risk for cardiometabolic
events. This would be the result even if WC is not mea-
sured and actual WC measurements are not available.
As well, an alternative model is available for practi-
tioners and researchers to whom data on race or ethni-
city are not readily available.
The model is generalizable to Caucasian and African-
American adult populations because it was constructed
from data in a large, population-based sample of U.S.
men and women, and then validated in a population
with a larger representation of African-Americans. This
model has not been validated in non-Caucasian, non-
African-American ethnic groups. Further work in that
regard should be conducted.
Although the model successfully estimates WC and,
using the WC estimate, membership in the risk clusters,
we observed a modest level of systematic error in the
model results. Specifically, the model tends to overesti-
mate the true WC in lower ranges of WC, and under-
estimate the true WC in upper ranges of WC,
particularly among women. Heterogeneity in the anthro-
pometry of women (e.g., obesity in hips, thighs, and
mammary tissue not measured by WC) compared with
men likely accounts for the greater mean differences in
the predicted and observed WC values for women as
compared with men. Efforts to identify a correction term
in the model for the NHANES data were unsuccessful.
However, the magnitude of the systematic error is suffi-
ciently small that using the estimated WC to identify
cardiometabolic risk is accurate in both genders, and
slightly better for women.
Conclusions
The model accurately estimates WC and identifies cardi-
ometabolic risk. It should be useful for health care prac-
titioners and public health officials who wish to identify
individuals and populations at risk for cardiometabolic
disease when WC data are unavailable.
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